This may also have to do with the supply not able to meet the demand for weight loss drugs offered by Novo Nordisk in the USA and there was shortage of Ozempic, Wegovy, Mounjaro and Zepbound there.
The FDA site link with updated status is below
| Subscribe To Our Free Newsletter |
